BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:56 PM
 | 
Jul 01, 2019
 |  BC Extra  |  Company News

Management Tracks: BioCryst hires its first CBO; plus ObsEva, Veracyte and more

Rare disease company BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) hired Megan Sniecinski as its first CBO. She was SVP of business operations and program management at PTC Therapeutics Inc. (NASDAQ:PTCT).

Reproductive health company ObsEva S.A. (NASDAQ:OBSV; SIX:OBSN) hired Elizabeth Garner as CMO. She succeeds CMO Elke Bestel, who will become VP, head of drug safety and pharmacovigilance. Garner was CMO, SVP clinical development at Agile Therapeutics Inc. (NASDAQ:AGRX).

Veracyte Inc....

Read the full 320 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >